Reduced risk of CIN2+ recurrence in women immunized with a 9-valent HPV vaccine post-excision: Retrospective cohort study
ABSTRACTThe main aim of our study was to investigate the specific contribution of a 9-valent human papillomavirus vaccine (9vHPV) to the recurrence risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) in women vaccinated post-excision. Therefore, we conducted a retrospective monocentr...
Saved in:
Main Authors: | Vladimír Dvořák (Author), Marek Petráš (Author), Danuše Lomozová (Author), Pavel Dlouhý (Author), Ivana Králová Lesná (Author), Radovan Pilka (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SARS-CoV-2 vaccination in the context of original antigenic sin
by: Marek Petráš, et al.
Published: (2022) -
Spotlight on the 9-valent HPV vaccine
by: Lopalco PL
Published: (2016) -
CURRENT APPROACHES FOR HPV-ASSOCIATED CIN
by: Татьяна Владимировна Клинышкова, et al.
Published: (2020) -
Progression of CIN1/LSIL HPV Persistent of the Cervix: Actual Progression or CIN3 Coexistence
by: Maria Teresa Bruno, et al.
Published: (2021) -
Post-marketing study design to evaluate the effectiveness of the 9-valent and 4-valent HPV vaccines on serious HPV-related cervical disease in China
by: Yu Yang, et al.
Published: (2024)